|
參考文獻
1.Mark Bamford, Gail Walkinshaw, Robin Brown (2000) Therapeutic applications of apoptosis research. Experimental Cell Research 256; 1-11
2.H. N. Crans, K. M. Sakamoto (2001) Transcription factors and translocations in lymphoid and myeloid leukemia. Leukemia 15; 313-331
3.血液學 ( TEXTBOOK OF HEMATOLOGY ) 第二版 何敏夫 編著
4.Bayard L. Powell (2001) Acute progranulocytic leukemia. Current Opinion in Oncology 13; 8-13
5.Amit Verma, Wendy Stock (2001) Management of acute lymphoblastic leukemia: moving toward a risk-adapted approach. Current Opinion in Oncology 13; 14-20
6.Michael J. Mauro, Brian J. Druker (2001) Chronic myelogenous leukemia. Current Opinion in Oncology 13; 3-7
7.T. A. McDonald, N.T. Holland, C. Skibola, P. Duramad, M. T. Smith (2001) Hypothesis: phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia. Leukemia 15; 10-20
8.X. Cai, Y. L. Shen, Q Zhu, P. M. Jia, Y. Yu, L. Zhou, Y. Huang, J. W. Zhang, S. M. Xiong, S. J. Chen, Z. Y. Wang, Z. Chen, G. Q. Chen (2000) Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia 14; 262-270
9.G. Q. Chen, J. Zhu, X. G. Shi, J. H. Ni, H. J. Zhong, G. Y. Si, X. L. Jin, W. Tang, X. S. Li, S. M. Xong, Z. X. Shen, G. L. Sun, J. Ma, P. Zhang, T. D. Zhang, C. Gazin, T. Naoe, S. J. Chen, Z. Y. Wang, Z. Chen (1996) In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RARα/PML proteins. Blood 88; 1052-1061
10.G. Q. Chen, X. G. Shi, W. Tang, S. M. Xiong, J. Zhu, X. Cai, Z. G. Han, J. H. Ni, G. Y. Shi, P. M. Jia, M. M. Liu, K. L. He, C. Niu, J. Ma, P. Zhang, T. D. Zhang, P. Paul, T. Naoe, K. Kitamura, W. Miller, S. Waxman, Z. Y. Wang, Hugues de The, S. J. Chen, Z. Chen (1997) Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood 89; 3345-3353
11.Marcia I. Dawson, Elena Elstner, Masahiro Kizaki, Dan-Lin Chen, Seppo Pakkala, Berit Kerner, H. Phillip Koeffler (1994) Myeloid differentiation mediated through retinoic acid receptor/ retinoic X recepter (RXR) not RXR/RXR pathway. Blood 84; 446-452
12.Anna Dipietrantonio, Tze-chen Hsieh, Joseph M. Wu (1996) Differential effects of retinoic acid (RA) and N-(4- Hydroxyphenyl) retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34cdc2, Bcl-2, and actin expression in human promyelocytic HL-60 leukemia cells. Biochemical and Biophysical Research Communications 224; 837-842
13.Yves Carpentier, Philippe Mayer, Helene Bobichon, Bernard Desoize (1998) Cofactors in vitro induction of apoptosis in HL60 cells by all-trans retinoic acid (ATRA). Biochemical Pharmacology 55; 177-184
14.Z. X. Shen, G. Q. Chen, J. H. Ni, X. S. Li, S. M. Xiong, Q. Y. Qiu, J. Zhu, W. Tang, G. L. Sun, K. Q. Yang, Y. Chen, L. Zhou, Z. W. Fang, Y. T. Wang, J. Ma, P. Zhang, T. D. Zhang, S. J. Chen, Z. Chen, Z. Y. Wang (1997) Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. clinical efficacy and pharmacokinetics in relapsed patients. Blood 89; 3354-3360
15.M. E. Huang, Y. C. Ye, S. R. Chen, J. R. Chai, J. X. Lu, L. Zhoa, L. J. Gu, Z. Y. Wang (1988) Use of all-trans retinoic acid in treatment of acute promyelocytic leukemia. Blood 72; 567-572
16.Stanley R. Frankel, Anna Eardley, Gregory Lauwers, Mark Weiss, Raymond P. Warrell (1992) The “retinoic acid syndrome” in acute promyelocytic leukemia. Annals of Internal Medicine 117; 292-296
17.J. F. Kerr, A. H. Willie, A. R. Currie (1972) Apoptosis:a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26; 239-257
18.A. H. Willie, J. F. Kerr, A. R. Currie (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol. 68; 251-306
19.J. F. Kerr, C. M. Winterford, B.V. Harmon (1994) Apoptosis-its significance in cancer and cancer therapy. Cancer 73; 2013-2026
20.Alan G. Porter, Reiner U. Janicke (1999) Emerging roles of caspase-3 in apoptosis. Cell death and differentiation 6; 99-104
21.Clemens A. Schmitt, Scott W. Lowe (1999) Apoptosis and therapy. Journal of pathology 187; 127-137
22.Paul A. Colussi, Sharad Kumar (1999) Targeted disruption of caspase genes in mice: What they tell us about the functions of individual caspases in apoptosis. Immunology and Biology 77; 58-63
23.Kay-Oliver Kliche, Klaus Hoffken (1999) The role of apoptosis in hematologic malignancies and modulation of apoptosis as a new therapeutic approach. J. Cancer Res. Clin. Oncol. 125; 226-231
24.Scott W. Lowe, Athena W. Lin (2000) Apoptosis in cancer. Carcinogenesis 21; 485-495
25.S. Bialik, T. Gottlieb (2000) Death at the dead sea. Cell Death and Differeatiation 7; 851-859
26.Ella Bossy-Wetzel, Douglas R. Green (1999) Apoptosis: checkpoint at the mitochondrial frontier. Mutation Research 434; 243-251
27.Shawn B. Bratton, Marion MacFarlane, Kelvin Cain, Gerald M. Cohen (2000) Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis. Experimental Cell Research 256, 27-33
28.Shigekazu Nagata (2000) Apoptosis DNA fragmentation. Experimental cell research 256; 12-18
29.Bruno Antonsson, Jean Claude Martinou (2000) The Bcl-2 protein family. Experimental Cell Research 256; 50-57
30.K. M. Murphy, V. Ranganathan, M.L. Farnsworth, M. Kavallaris, R. B. Lock (2000) Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death and Differentiation 7; 102-111
31.Liam O’Connor, David CS Huang, Lorraine A O’Reilly, Andreas Strasser (2000) Apoptosis and cell division. Current Opinion in Cell Biology 12; 257-263
32.Jing Yang, Sally Kornbiuthm (1999) All aboard the cyclin train: subcellular trafficking of cyclins and their CDK partners. Cell Biology 9; 207-210
33.E. Hulleman, J. Boonstra (2001) Regulation of G1 phase progression by growth factors and the extracellular matrix. Cell Mol. Life Sci. 58; 80-93
34.Robin Leake. The cell cycle and regulation of cancer cell growth. Annals New York Academy of Sciences; 252-262
35.Giulio Draetta, Jens Eckstein (1997) Cdc25 protein phosphatases in cell proliferation. Biochimica et Biophysica Acta 1332; 53-63
36.J. Slingerland, M. Pagano (2000) Regulation of the Cdk inhibitor p27 and its deregulation in cancer. Journal of Cellular Physiology 183; 10-17
37.G. Paolo Dotto (2000) p21WAF1/Cip1: more than a break to the cell cycle. Biochimica et Biophysica Acta 1471; 43-56
38.Masataka Itoigawa, Yoshiki Kashiwada, Chihiro Ito, Hiroshi Furukawa, Yoko Tachibana, Kenneth F. Bastow, Kuo-Hsiung Lee (2000) Anticancer agents. 203 carbazole alkaloid murrayaquinone A and related synthetic carbazolequinones as cytotoxic agents. Journal of Natural Products 63; 893-897
39.Lawrence S. Chin, Susan F. Murray, Patrick F. Doherty, Satyendra K.Singh. (1999) K252a induces cell cycle arrest and apoptosis by inhibiting cdc2 and cdc25c. Cancer Investigation 17; 391-395
40.Yoshinari Tomoki, Matsumoto Mami, Arakawa Hiroharu, Okada Hiromasa, Noguchi Kazuo, Suda Hiroyuki, Okura Akira, Nishimura Susumu. (1995) Novel anticancer indolocarbazole compound 6-N-formylamino-12,13-dihydro-1,11-dihydro-13-(β-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione(NB-506):Induction of topoisomerase I-mediated DNA cleavage and mechanisms of cell line-selective cytotoxicity. Cancer Reaearch 55; 1310-1315
41.H. P. Koeffler, D. W. Golde (1980) Human myeloid leukemia cell lines: A review. Blood 56; 344-350
42.Christer Sundstrom, Kenneth Nilsson (1976) Establishment and characterization of a human histiocytic lymphoma cell line (U937) Int. J. Cancer 17; 565-577
43.Richard M. Lewis, John C. Morrill, Peter B. Jahrling, Thomas M. Cosgriff. (1989) Replication of hemorrhage fever viruses in monocytic cells. Reviews of Infectious Diseases 11; S736-S742
44.C. D. Jun, H. O. Pae, J. C. Yoo, H. J. Kwak, R. K. Park, H. T. Chung (1998) Cyclin adenosine monophosphate inhibits nitric oxide-induced apoptosis in human leukemia HL-60 cells. Cellular Immunology 183; 13-21
45.Y. J. Surh, Y. J. Hurh, J. Y. Kang, E. Lee, G. Kong, S. J. Lee (1999) Resveratrol, an antioxidant present in red wine, induced apoptosis in human promyelocytic leukemia (HL60) cells. Cancer Letters 140; 1-10
46.Consuelo Gajate, Isabel Barasoain, Jose M. Andreu, Faustino Mollinedo (2000) Induction of apoptosis in leukemia cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2’,3’,4’-tri methoxyphenyl)- 2,4,6-cycloheptatrien-1-one:protection by Bcl-2 and Bcl-XL and cell cycle arrest. Cancer Research 60; 2651-2659
47.F. Durrieu, F. Belloc, L. Lacoste, P. Dumain, J. Chabrol, J. Dachary-prigent, H. Morjani, M. R. Boisseau, J. Reiffers, Ph. Bernard, F. Lacombe (1998) Caspase activation is an early event in anthracyclin- induced apoptosis and allows detection of apoptosis cells before they are ingested by phagocytes. Experimental Cell Research 240; 165-175
48.Nariyoshi Shinomiya, Yukie Kuno, Fuyumi Yamamoto, Masashi Fukasawa, Atsushi Okumura, Megumi Uefuji, Makoto Rokutanda (2000) Different mechanisms between premitotic apoptosis and postmitotic apoptosis in X-irradiated U937 cells. Int. J. Radiation Oncology Biol. Phys. 47; 767-777
49.Catheryne Chen, Hong Lin, Chachata Karanes, Georeg R. Pettit, Ben D. Chen (2000) Human THP-1 monocytic leukemia cells induced to undergo monocytic differentiation by Bryostatin 1 are refractory to Proteasome inhibitor-induced apoptosis. Cancer Research 60; 4377-4385
50.Min Lu, Jack Levin, Eric Sulpice, Anabelle Sequeira-Le Grand, Monica Alemany, Jacques P. Caen, and Zhong Chao Han (1999) Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines. Experimental Hematology 27; 845-852
51.Shougang Zhuang, Mary C. Lynch, Irene E. Kochevar (1999) Caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis of HL-60 cells. Experimental Cell Research 250; 203-212
52.A. Benito, A. Lerga, M. Silva, J. Leon, L.J.L. Fernandez (1997) Apoptosis of human myeloid leukemia cells induced by an inhibitor of protein phosphatases (okadaic acid) is prevented by Bcl-2 and bcl-x(L). Leukemia 11; 940-944
53.William R Taylor, George R Stark (2001) Regulation of the G2/M transition by p53. Oncogene 20; 1803-1815
54.Faina Vikhanskaya, Sara Vignati, Patrizia Beccaglia, Cristina Ottoboni, Patrizia Russo, Maurizio D’Incalci, Massimo Broggini (1998) Inactivation of p53 in human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis. Experimental Cell Research 241; 96-101
55.Masaaki Shiohara, Makoto Akashi, Adrian F. Gombart, Rong Yang, H. Phillip Koeffler (1996) Tumor necrosis factor α：posttranscriptional stabilization of WAF1 mRNA in p53-deficient human leukemic cells. Journal of Cellular Physiology 166; 568-576
56.K. Saeki, A.You, E. Okuma, Y. Yazaki, S. A. susin, G. Kroemer, F. Takaku (2000) Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells. Cell Death and Differentiation 7; 1263-1269
57.Marc-Antoine Belaud-Rotureau, Francis Lacombe, Francoise Durrieu, Jean-Philippe Vial, Laurent Lacoste, Philippe Brernard, Francis Belloc (1999) Ceramide-induced apoptosis occurs independently of caspases and is decreased by leupeptin. Death and Differentiation 6; 788-795
58.Oliver Micheau, Eric Solary, Arlette Hammann, Marie-Therese, Dimanche-Boitrel (1999) Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. The Journal of Biological Chemistry 274; 7987-7992
59.A. M. Ibrado, C. N. Kim, K. Bhalla (1998) Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome c and caspase 3 activity during Taxol-induced apoptosis of human AML HL-60 cells. Leukemia 12; 1930-1936
60.Yi-He Ling, Carmen Tornos, Roman Perez-Soler (1998) Phophorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis. The Journol of Biological Chemistry 273; 18984-18991
61.Diane E. McCloskey, Scott H. Kaufmann, Laura J. Prestigiacomo, Nancy E. Davidson (1996) Paclitaxol induces programmed cell death in MDA-MB-468 human breast cancer cells. Clinical Cancer Research 847; 847-854
62.Dan L. Wod, Dulal Panda, Todd R. Wiernicki, Leslie Wilson, Mary Ann Jordan, Jai Pal Singh (1997) Inhibition of mitosis and microtubule function through direct tubulin binding by a novel antiproliferation naphthopyran LY290181. Molecular Pharmacology 52; 437-444
63.Susan L. Mooberry, Lizette Busquets, Georgia Tien (1997) Induction of apoptosis by cryptophycin 1, a new antimicrotubule agent. Int. J. Cancer 73; 440-448
64.Susan L. Mooberry, Georgia Tien, Anne H. Heranadez, Anuchit Plubrukarn, Bradley S. Davidson (1999) Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents. Cancer Research 59; 653-660
65.Jian-Dong Jiang, Ashley S. Davis, Kim Middleton, Yi-He Ling, Roman Perez-Soler, James F. Holland, J. George Bekesi (1998) 3-(Indoacetamido)-benzoylurea：a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphrylates bcl-2, and induces apoptosis in tumor cells. Cancer Research 58, 5389-5395
|